首页 | 本学科首页   官方微博 | 高级检索  
     


The Fas counterattack: cancer as a site of immune privilege
Authors:O'Connell J  Bennett M W  O'Sullivan G C  Collins J K  Shanahan F
Affiliation:Dept of Medicine, Cork University Hospital, Ireland. J.OConnell@ucc.ie
Abstract:Resistance to apoptosis through the Fas receptor pathway coupled with expression of the Fas ligand might enable many cancers to deliver a pre-emptive strike or counterattack against the immune system. Therapeutic exploitation of this has exciting potential, but now seems more complex and hazardous than was first evident.
Keywords:
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号